Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas
Open Access
- 26 August 2010
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 1 (6) , 921-926
Abstract
Juvenile nasopharingeal angiofibroma (JNA) is a histologically benign locally aggressive tumor characterized by irregular vessels embedded in a fibrous stroma. Excessive vascularity results in bleeding complications, and the inhibition of angiogenesis is a promising strategy for managing extensive JNA tumors. To better characterize the endothelial components of JNA, we aimed to evaluate markers of vascular differentiation and proliferation, such as friend leukemia integration-1 (FLI-1) and endoglin, lymphatic markers, including podoplanin and vascular endothelial growth factor receptor 3 (VEGFR3) and its cognate ligand VEGFC, GLUT-1, a diagnostic marker that discriminates between hemangiomas and vascular malformations, and two markers of tissue remodeling, stromelysin 3 (ST3) and secreted acid protein rich in cysteine (SPARC). Antigens were assessed immunohistochemically in vessels and stromal cells of JNA archival cases (n=22). JNA endothelial cells were positive for endoglin, VEGFC and FLI-1, whereas podoplanin and VEGFR3 were negative in all cases. Both endothelial cells and fibroblasts stained for ST3 and SPARC. GLUT-1 was investigated in JNA cases, in infantile hemangiomas (n=123) and in vascular malformations (n=135) as controls. JNAs and vascular malformations were GLUT-1-negative, while hemangiomas showed positive staining. The presence of markers of endothelial differentiation and proliferation highlighted the hyper-proliferative state of JNA vessels. The absence of podoplanin and VEGFR3 underscores their blood endothelial cell characteristic. The absence of GLUT-1 discriminates JNAs from hemangiomas. ST3 and SPARC up-regulation in endothelial cells and fibroblasts may contribute to a compensatory signaling for controlling angiogenesis. Some of these markers may eventually serve as therapeutic targets. Our results may aid in the understanding of JNA pathophysiology.Keywords
This publication has 42 references indexed in Scilit:
- Why are tumour blood vessels abnormal and why is it important to know?British Journal of Cancer, 2009
- Nasopharyngeal angiofibroma with intracellular accumulation of SPARC – a hypothesis (SPARC in nasopharyngeal angiofibroma)Medical Hypotheses, 2008
- Expression of Collagen Types I, II and III in Juvenile AngiofibromasCells Tissues Organs, 2008
- Molecular heterogeneity of tumor endotheliumCell and tissue research, 2008
- Causes and Consequences of Increased Glucose Metabolism of CancersJournal of Nuclear Medicine, 2008
- Laminin expression in juvenile angiofibroma indicates vessel's early developmental stageActa Oto-Laryngologica, 2007
- SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrixInternational Journal of Cancer, 2005
- Overexpression of Fos‐related antigen‐1 in head and neck squamous cell carcinomaInternational Journal of Experimental Pathology, 2005
- Induction of SPARC by VEGF in Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 2001
- Ontogeny of the erythroid/HepG2-type glucose transporter (GLUT-1) in the rat nervous systemDevelopmental Brain Research, 1993